183 related articles for article (PubMed ID: 18287458)
1. Imaging features of sarcoidosis on MDCT, FDG PET, and PET/CT.
Prabhakar HB; Rabinowitz CB; Gibbons FK; O'Donnell WJ; Shepard JA; Aquino SL
AJR Am J Roentgenol; 2008 Mar; 190(3 Suppl):S1-6. PubMed ID: 18287458
[TBL] [Abstract][Full Text] [Related]
2. PET/CT in the Diagnosis and Workup of Sarcoidosis: Focus on Atypical Manifestations.
Akaike G; Itani M; Shah H; Ahuja J; Yilmaz Gunes B; Assaker R; Behnia F
Radiographics; 2018; 38(5):1536-1549. PubMed ID: 30118393
[TBL] [Abstract][Full Text] [Related]
3. FDG PET/CT in bone sarcoidosis.
Grozdic Milojevic I; Sobic-Saranovic D; Videnovic-Ivanov J; Saranovic D; Odalovic S; Artiko V
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Mar; 33(1):66-74. PubMed ID: 27055838
[TBL] [Abstract][Full Text] [Related]
4. Hybrid Imaging in Evaluation of Abdominal Sarcoidosis.
Milojevic IG; Sobic-Saranovic D; Petrovic N; Beatovic S; Tadic M; Artiko VM
Curr Med Imaging Rev; 2019; 15(1):26-31. PubMed ID: 31964324
[TBL] [Abstract][Full Text] [Related]
5. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L
Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
[TBL] [Abstract][Full Text] [Related]
6. Atypical Presentation of Sarcoidosis on ¹⁸F-FDG PET/CT.
Jolepalem P; McLean KZ; Wong CY
J Nucl Med Technol; 2014 Jun; 42(2):114-5. PubMed ID: 24627413
[TBL] [Abstract][Full Text] [Related]
7. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
8. FDG-positron emission tomographic imaging in carcinoma of the breast: interference by massive sarcoidosis.
Garcia CA; Rosenberg RJ; Spencer RP
Clin Nucl Med; 2003 Mar; 28(3):218-9. PubMed ID: 12592129
[No Abstract] [Full Text] [Related]
9. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
Teirstein AS; Machac J; Almeida O; Lu P; Padilla ML; Iannuzzi MC
Chest; 2007 Dec; 132(6):1949-53. PubMed ID: 17925421
[TBL] [Abstract][Full Text] [Related]
10. Multi-technique imaging of sarcoidosis.
Balan A; Hoey ET; Sheerin F; Lakkaraju A; Chowdhury FU
Clin Radiol; 2010 Sep; 65(9):750-60. PubMed ID: 20696303
[TBL] [Abstract][Full Text] [Related]
11. The scar sign: a useful finding on FDG PET/CT to distinguish sarcoidosis from other causes of lymphadenopathy.
Lu SJ; Lee VK; Loo SW
Clin Nucl Med; 2013 Mar; 38(3):205-8. PubMed ID: 23354040
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis.
Nishiyama Y; Yamamoto Y; Fukunaga K; Takinami H; Iwado Y; Satoh K; Ohkawa M
J Nucl Med; 2006 Oct; 47(10):1571-6. PubMed ID: 17015889
[TBL] [Abstract][Full Text] [Related]
13. Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis.
Dubey N; Miletich RS; Wasay M; Mechtler LL; Bakshi R
J Neurol Sci; 2002 Dec; 205(1):77-81. PubMed ID: 12409188
[TBL] [Abstract][Full Text] [Related]
14. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
15. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.
Aide N; Benayoun M; Kerrou K; Khalil A; Cadranel J; Talbot JN
Br J Radiol; 2007 Mar; 80(951):e67-71. PubMed ID: 17548505
[TBL] [Abstract][Full Text] [Related]
16. Cervical and axillary lymph node sarcoidosis misdiagnosed as lymphoma on F-18 FDG PET-CT.
Li YJ; Zhang Y; Gao S; Bai RJ
Clin Nucl Med; 2007 Mar; 32(3):262-4. PubMed ID: 17314619
[No Abstract] [Full Text] [Related]
17. Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotide.
Avram AM; Mackie GC; Schneider BJ; Kalemkerian GP; Shulkin BL
Clin Nucl Med; 2006 Apr; 31(4):197-200. PubMed ID: 16550010
[TBL] [Abstract][Full Text] [Related]
18. [Sarcoidosis-lymphoma syndrome].
Partanen A; Pukkila S; Jantunen E
Duodecim; 2016; 132(7):661-5. PubMed ID: 27188091
[TBL] [Abstract][Full Text] [Related]
19. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
Junginger T; Kneist W; Schreckenberger M; Menzel C; Oberholzer K; Bartenstein P
Dtsch Med Wochenschr; 2002 Sep; 127(38):1935-41. PubMed ID: 12239652
[TBL] [Abstract][Full Text] [Related]
20. F-18 FDG PET: mottled splenomegaly with remission of symptoms after splenectomy in sarcoidosis.
Vento JA; Arici M; Spencer RP; Sood R
Clin Nucl Med; 2004 Feb; 29(2):103-4. PubMed ID: 14734908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
